+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & Reagents), Application, Cancer Type, End Users - Global Forecast 2025-2030- Product Image
Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & Reagents), Application, Cancer Type, End Users - Global Forecast 2025-2030- Product Image
Sale

Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & Reagents), Application, Cancer Type, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311178
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The circulating tumor cell (CTC) market is advancing quickly, driven by new technologies transforming cancer diagnostics and research. Senior decision-makers face increasing opportunities and technical challenges as CTC analysis moves to the forefront of precision oncology and drug development.

Market Snapshot: Circulating Tumor Cell Market Growth & Opportunity

The circulating tumor cell market grew from USD 12.82 billion in 2024 to USD 14.10 billion in 2025. It is projected to continue expanding at a CAGR of 10.25%, reaching USD 23.02 billion by 2030. This upward trajectory reflects growing global demand for noninvasive cancer detection, real-time monitoring, and application in research and clinical settings.

Scope & Segmentation: CTC Market Landscape

  • Technology Type: CTC analysis and CTC detection & isolation technologies, including immunomagnetic separation and microfluidic-based separation methods.
  • Product Type: Instruments, kits & reagents designed to support both detection and complex molecular profiling.
  • Application: Solutions tailored for clinical diagnostics & research and drug development, facilitating the transition from discovery to clinical use.
  • Cancer Type: Technologies applicable across breast, colorectal, lung, and prostate cancers, supporting early detection, therapeutic response monitoring, and understanding of resistance mechanisms.
  • End Users: Adoption among diagnostic centers, hospitals & clinics, and research & academic institutes varies according to throughput needs, analytical depth, and cost requirements.
  • Geographical Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, and additional countries).
  • Leading Companies: Includes Advanced Cell Diagnostics, Bio-Techne Corporation, BioFluidica, Biolidics Limited, Creatv MicroTech, Epic Sciences, Fluxion Biosciences by Cell Microsystems, Greiner Bio-One International, Ikonisys, LungLife AI, Menarini Silicon Biosystems, Miltenyi Biotec, Precision Medicine Group, QIAGEN, Rarecells Diagnostics, ScreenCell, SRI International, STEMCELL Technologies, Sysmex Corporation, Thermo Fisher Scientific, and others.

Key Takeaways: Strategic Insights for Decision-Makers

  • Continued innovation in microfluidic and immunocapture platforms is expanding CTC recovery rates and driving adoption in high-throughput settings.
  • Integration with artificial intelligence and digital analytics is enhancing the value of CTC assays, enabling more nuanced molecular profiling and predictive insights into therapeutic response.
  • Regional adoption patterns are shaped by factors including regulatory cohesion, research funding structures, and infrastructure maturity, particularly distinguishing markets in the Americas, EMEA, and Asia-Pacific.
  • Collaborative developments and targeted acquisitions among established biotechnology companies and startups have improved platform capabilities, workflow integration, and real-time clinical relevance.
  • Distinct use cases in early cancer detection, personalized medicine, and drug discovery are fueling demand across varied clinical and research contexts, strengthening the case for investment in CTC technologies.

Tariff Impact on Circulating Tumor Cell Research & Supply Chains

Recent changes in United States tariff policy have introduced new import duties on essential laboratory instruments and reagents for CTC research. This has resulted in increased costs, longer lead times, and greater complexity in procurement and supply chain management. Stakeholders are responding by exploring domestic sourcing, local manufacturing partnerships, and collaborative procurement to minimize disruption and support ongoing innovation.

Methodology & Data Sources

Research for this report integrates comprehensive secondary analysis of peer-reviewed literature, regulatory documents, and industry white papers alongside primary interviews with industry executives and scientific leaders. Rigorous validation processes, including cross-referencing and data triangulation, ensure findings are both credible and actionable.

Why This Report Matters

  • Enables senior leaders to understand evolving CTC technology trends and their business impact on diagnostics, research, and drug development.
  • Delivers actionable intelligence on market shifts, regulatory dynamics, supply chain risks, and emerging regional opportunities.
  • Equips organizations to benchmark technology investments and align strategic planning with the latest industry standards and adoption patterns.

Conclusion

The circulating tumor cell market is advancing through rapid innovation, strategic collaboration, and diversification of applications. Decision-makers equipped with this knowledge are positioned to capitalize on growth opportunities and mitigate operational risks as CTC technologies shape the next era of oncology and precision medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of high-sensitivity microfluidic platforms for CTC enumeration in early cancer screening
5.2. Integration of single-cell genomic profiling of CTCs for personalized oncology treatment decisions
5.3. Adoption of label-free CTC detection technologies utilizing dielectrophoresis for unbiased cell capture
5.4. Advancements in CTC-derived xenograft models for accelerated preclinical drug efficacy evaluation
5.5. Regulatory pathway harmonization efforts for CTC-based liquid biopsy kits in global markets
5.6. Integration of artificial intelligence algorithms for automated classification of CTC morphological phenotypes
5.7. Commercialization of microbead-based immunomagnetic CTC isolation devices with enhanced throughput
5.8. Use of CTC molecular heterogeneity metrics to predict metastatic risk and guide targeted therapy selection
5.9. Development of point-of-care CTC analysis systems leveraging lab-on-a-chip integration for clinical settings
5.10. Emerging partnerships between diagnostic and pharmaceutical companies for CTC companion diagnostic platforms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Circulating Tumor Cell Market, by Technology Type
8.1. Introduction
8.2. CTC Analysis
8.3. CTC Detection & Isolation
8.3.1. Immunomagnetic Separation
8.3.2. Microfluidic-Based Separation
9. Circulating Tumor Cell Market, by Product Type
9.1. Introduction
9.2. Instruments
9.3. Kits & Reagents
10. Circulating Tumor Cell Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics & Research
10.3. Drug Development
11. Circulating Tumor Cell Market, by Cancer Type
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. Circulating Tumor Cell Market, by End Users
12.1. Introduction
12.2. Diagnostic Centers
12.3. Hospital & Clinics
12.4. Research & Academic Institutes
13. Americas Circulating Tumor Cell Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Circulating Tumor Cell Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Circulating Tumor Cell Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Cell Diagnostics, Inc.
16.3.2. Bio-Techne Corporation
16.3.3. BioFluidica
16.3.4. Biolidics Limited
16.3.5. Creatv MicroTech, Inc.
16.3.6. Epic Sciences
16.3.7. Fluxion Biosciences, Inc. by Cell Microsystems
16.3.8. Greiner Bio-One International GmbH
16.3.9. Ikonisys, Inc.
16.3.10. LungLife AI, Inc.
16.3.11. Menarini Silicon Biosystems
16.3.12. Miltenyi Biotec GmbH
16.3.13. Precision Medicine Group, LLC
16.3.14. QIAGEN N.V.
16.3.15. Rarecells Diagnostics
16.3.16. ScreenCell
16.3.17. SRI International
16.3.18. STEMCELL Technologies, Inc.
16.3.19. Sysmex Corporation
16.3.20. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CIRCULATING TUMOR CELL MARKET: RESEARCHAI
FIGURE 26. CIRCULATING TUMOR CELL MARKET: RESEARCHSTATISTICS
FIGURE 27. CIRCULATING TUMOR CELL MARKET: RESEARCHCONTACTS
FIGURE 28. CIRCULATING TUMOR CELL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOMAGNETIC SEPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOMAGNETIC SEPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED SEPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED SEPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL DIAGNOSTICS & RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL DIAGNOSTICS & RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 90. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 91. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 102. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 153. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 164. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 165. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 176. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 189. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 190. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 191. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 200. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 201. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 212. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 249. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 260. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 273. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 274. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 275. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 282. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 283. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 284. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 285. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 294. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 296. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 321. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2024 (USD MILLION)
TABLE 324. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2025-2030 (USD MILLION)
TABLE 325. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. EGYPT CIRCULATING TUMOR CE

Samples

Loading
LOADING...

Companies Mentioned

  • Advanced Cell Diagnostics, Inc.
  • Bio-Techne Corporation
  • BioFluidica
  • Biolidics Limited
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc. by Cell Microsystems
  • Greiner Bio-One International GmbH
  • Ikonisys, Inc.
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec GmbH
  • Precision Medicine Group, LLC
  • QIAGEN N.V.
  • Rarecells Diagnostics
  • ScreenCell
  • SRI International
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.02 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033 - Product Image

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032 - Product Image

Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report - Product Image

Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report

  • Report
  • 132 Pages
  • Global
From

About the Circulating Tumor Cell Market

Circulating Tumor Cells (CTCs) are a type of biomarker used to detect and monitor cancer. CTCs are cells that have been shed from a tumor and are present in the bloodstream. They can be used to diagnose cancer, monitor its progression, and assess the effectiveness of treatments. CTCs are also used to identify new therapeutic targets and to develop personalized treatments. CTCs are a rapidly growing market, with a range of products and services available to researchers and clinicians. Companies in the CTC market offer technologies for isolating, analyzing, and characterizing CTCs, as well as services for CTC-based diagnostics and drug development. Examples of companies in the CTC market include ApoCell, Menarini Silicon Biosystems, and RareCyte. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.